Alpha-Rich Ideas
Brookfield Office Properties Is An Out Of Favor Real Estate Play
by Mike Arnold
Editor's notes: While BPO has a well-known expiring lease to refill, the effect on the stock is overdone. The shares offer good downside protection and 20-30% upside.
Financial Engines: Growth Mission Impossible
by Akram's Razor
Editor's notes: FNGN's valuation discounts near-impossible growth rates and suggests the company has been lumped in with the wrong peer group. Fund manager Akram's Razor sees considerable downside.
Breaking Alpha-Rich Ideas (for Pro Subscribers. Learn more»)
Programming Refresh Equals Big Rewards For This Company by Shaun Currie, CFA
Time To Buy This Tech by Ashraf Eassa
Undervalued As Restructuring Moves Forward by Helix Investment Research
Company Is Very Cheap by Saj Karsan
Long Ideas
Cameron International: Venturing Towards New Depths by Doug Sheridan
For Arena, Belviq Refills Are Becoming Key by Spencer Osborne
Finavera Wind Energy: Slow Progress by Tom Konrad
One Reason Why You Shouldn't Ignore Semiconductors This Fall by Todd Campbell
Starbucks: Technology, International Growth, Food, And K-Cups All Point To A Bright Future by Jayson Derrick
A Promising Future For Anthera's Blisibimod by Blair O'Neill
Pacira Pharmaceuticals: Slow And Steady Wins The Race by Futuristics
Tiger Media Has Found Its Roar by Milwaukee Private Wealth Management, Inc
Atrium European Real Estate - Too Cheap To Ignore by The Investment Doctor
Delta Apparel Will Outperform Thanks To Growing Brands by Martin Vlcek
Cliffs Natural Resources: Will There Be A Sunshine? by Fusion Research
Bristol-Myers: Interesting Investing Opportunity With Onglyza by Fusion Research
Nike - Fresh All-Time Highs? Nike Just Did It by The Value Investor
Why Mondelez Is A Strong Buy by Fusion Research
Salesforce.com Creates A $30 Billion Industry by Leah Frakes
Vector Group: Buy A Portion Of Phillip Frost's Investment Portfolio And More With This Diverse Company by Charles Fox
Cisco Systems Is Upgrading Its Networking Offerings To Be More Software Defined by Jay Wei
MFC Industrial: Misunderstood And Undervalued With 45% Upside Potential by Alex B. Gray
Meritage Homes: Major Upside Potential In This Housing Name by The Oxen Group
Why You Should Keep Broadcom Under Your Radar? by Fusion Research
Pharmacyclics Up 45% In The Past 10 Weeks To A New All-Time High by Craig Brockie
MasterCard - The Star Performer by Price Point
Nike: Analyzing And Valuing The Athletic-Wear Company (Part II) by Michael Swyers
Philip Morris: Great Upside Due To 9% Free Cash Flow Profitability And Rising Dividends by Achilles Research
Nike: Analyzing And Valuing The Athletic-Wear Company (Part I) by Michael Swyers
Good Times To Return For Coal Producers by Equity Watch
LifeVantage Shows Significant Growth Is Coming by Volatility Research
Blyth/CVSL Conference Call Update by John Gilliam
Potential Deal Could Benefit These Two Undervalued Miners by Illuminati Investments
IBM Shares Lag, Just Like Buffett Wanted by Sean Weston
Vringo's Appeal Could Be Worth A Half Billion Dollars by Harris Schley
Manitowoc: Profit From Recovering World Economies by DAG1996
Industry Landscape Opens Doors For Pharmaceutical Company Polydex by The GeoTeam
Accumulate Accenture On Valuations And Industry Dynamics by Bottom Up Investing
Nu Skin: The New Ruler In The Land Of Novell by Bill Gunderson
Boingo: Bouncing Its Way 30% Higher With Offloading by Marshall Hargrave
American Capital Agency: Show Some Love For This mREIT by Boniface Murigu
Cantel Medical: Proven Aggressive Growth And Stock Returns by William Meyers
Total: Still A Solid Buy At These Levels? by Fusion Research
GM Is Accelerating Towards A Speedy Recovery by Mihir Mehta
Nike Takes Q1 - Why It Will Win The Whole Game by Markos Kaminis
Millenial Media Competing In High-Growth But Tough Segment by Sramana Mitra
Cameco Poised For Nuclear Upturn by Black Spruce
A Phase III Failure At Eli Lilly - Yes, Again by Derek Lowe
Arena Sales - Pacing Along Modestly by Spencer Osborne
Digging Deeper At Turkcell by Carl Livie
Buy Plug Power Before October 1st by PTSD Trader
With More Realistic Expectations, Itron Looks Interesting Again by Stephen Simpson, CFA
Lithia Motors: Buy New, Buy Used, Just Buy by Marshall Hargrave
CIBT Education Group Cashing In On Overseas Chinese Students by Stuart Wooldridge
Athlon Energy: A Permian Pure-Play With Deep Drilling Inventory by Price Point
Is Slowing Growth Limiting EMC's Upside? by ONeil Trader
Myers Industries: A Value Creation Story by Stock Gamer
Can Advanced Micro Devices Survive The Declining PC Market? by Fusion Research
Alphatec Holdings: An Undervalued Spine Player With A Potential Growth Opportunity by Biomed Group
The Apparent End Of The BlackBerry Presents Incremental Opportunities For Apple And Google by Silicon Valley Insights
Coherent: Stronger, Thinner Flat Panel Displays And Smaller Chips Offer Upside by Todd Campbell
Short Ideas
Windows 8.1 Will Not Save Intel by Kofi Bofah
3 More Things You Need To Know About Amazon.com by Paulo Santos
UDC's "Glaring Confessions" Contradict Its Claims. Confessions Were Made Unbeknownst To Investors And Analysts. by Manuel Asensio
Warren Buffett's 10 Points Of Light To Determine If He'd Invest In Verizon by Christopher Lum Lee
Why I Am Short ARM Holdings Inc. by Michael Blair
Pandora: The Next Apple Victim? by Fusion Research
Stay Away From This Sinking Ship by Adnan Riaz
Uni-Pixel Investors Getting Fooled Again by Alpha Exposure
J.C. Penney Dilutes By 30%, Avoid At All Costs by Quoth the Raven
SouthGobi: High Country Risk And Unprofitable Operations; 35% Overvalued Compared To Other Coal Companies by Elephant Analytics
Quick Picks & Lists
Analysts' Picks For The Dry Bulk Sector by MTF Investing
National Oilwell Varco: Publicly Traded Spin-Off To Create Shareholder Value by David Zanoni
Carnival Corporation: Buy Signals Can Surface by Stock Traders Daily
A 105% Gain For Facebook In 3 Months - And It's Time To Take Profits by StreetAuthority
Bull Of The Day: Star Bulk Carriers by Zacks Investment Research
Bear Of The Day: Avis Budget Group by Zacks Investment Research
Clear Skies For SolarCity by Green Energy Addict
Dry Bulk Shipping Going Higher In October by Robert Shurtz
AutoFill For Facebook Is A Winner by Kurt Windibank
Nektar's Faith In Pain Project Hurts Share Price by EP Vantage
Cyclacel Pharmaceuticals Preferred Shares: An Investigative Report by Scrying Biotech
3 Companies Developing The Future Of Cancer Therapy by The Swiss Trader
5 Stocks Affected By The Legalization Of Recreational Marijuana by The Specialist
Priceline: The Stock Price Is On The Line by Stock Traders Daily
More Buybacks On The Way In Packaging Industry by Morningstar
These Drug Makers Are Still Standing Strong by Fusion Research
Flu Season Remains A Growing Asset For Pharmacies by Volatility Research
3 Investment Ideas From The New iPhones by Renu Singh
Increasingly Important Lithium Production May Bring Future Profits To These Companies by David White
5 Biopharmas With Upcoming Catalysts That Should Rally by StockMatusow
Capitalizing On Cannabis: Divergence Among The Pot Stocks by Alan Brochstein
Apple Should Consider Buying Nuance And Here's Why by Amal Singh
Insider Ownership
Insiders Are Buying These Ultra High Yielders by Bret Jensen
IPO Analysis
Premier: Leading Provider In Supply Chain Management And Performance Services For Healthcare Industry. by Vivek Gupta
Foundation Medicine - Personalized Cancer Pharmaceutical IPO Fetches $1 Billion Valuation by The Value Investor
Ophthotech - Biopharmaceutical Public Offerings Remain In Demand by The Value Investor
Why are you receiving this? You subscribed to Investing Ideas at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.
To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.
Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001
No hay comentarios:
Publicar un comentario